Huadong Medicine Co., Ltd (SHE: 000963)

Huadong Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5,651	4,663	3,996	4,032	3,198	2,403
Cash & Short-Term Investments	5,651	4,663	3,996	4,032	3,198	2,403
Cash Growth	28.60%	16.69%	-0.90%	26.09%	33.10%	-1.64%
Accounts Receivable	9,635	8,896	8,210	6,940	6,966	6,776
Other Receivables	411.51	306.2	284.18	223.92	87.63	92.2
Receivables	10,047	9,203	8,494	7,164	7,054	6,868
Inventory	4,379	4,290	4,495	3,975	4,068	4,039
Prepaid Expenses	-	-	-	-	-	0.12
Other Current Assets	429.62	340.46	582.21	316.04	336.21	425.65
Total Current Assets	20,506	18,497	17,568	15,487	14,656	13,736
Property, Plant & Equipment	5,234	5,204	5,021	4,813	4,661	4,005
Long-Term Investments	2,107	2,101	2,020	1,243	1,076	464.27
Goodwill	2,592	2,599	2,441	2,139	1,470	1,470
Other Intangible Assets	2,486	2,334	2,280	2,233	1,463	1,455
Long-Term Deferred Tax Assets	233.15	187.81	152.84	143.65	137.83	116.16
Long-Term Deferred Charges	1,169	1,013	657.81	12.43	8.81	12.29
Other Long-Term Assets	1,840	1,574	1,051	925.63	729.86	205.84
Total Assets	36,167	33,509	31,192	26,996	24,201	21,464
Accounts Payable	6,976	6,102	5,902	4,520	4,501	4,402
Accrued Expenses	435.5	554.92	518.92	920.63	528.8	475.47
Short-Term Debt	1,625	1,197	1,337	1,627	1,808	1,048
Current Portion of Long-Term Debt	488.81	80.92	36.9	174.18	40.05	1,028
Current Portion of Leases	73.37	81.98	75.29	66.86	-	-
Current Income Taxes Payable	213.17	259.27	154.95	261.24	166.43	152.85
Current Unearned Revenue	126.78	136.85	147.64	119.49	95.34	254.89
Other Current Liabilities	3,355	2,389	1,979	1,576	1,494	1,035
Total Current Liabilities	13,293	10,803	10,153	9,266	8,634	8,397
Long-Term Debt	81.57	520.76	1,051	139.18	151.61	-
Long-Term Leases	69.08	56.7	84.61	80.89	-	-
Long-Term Unearned Revenue	158.89	171.06	126.12	83.52	81.63	60.96
Long-Term Deferred Tax Liabilities	173.39	184.37	202.08	184.91	88.74	39.6
Other Long-Term Liabilities	109.67	191.61	398.67	300.99	66.28	100.15
Total Liabilities	13,886	11,927	12,016	10,055	9,022	8,597
Common Stock	1,754	1,754	1,754	1,750	1,750	1,750
Additional Paid-In Capital	2,484	2,446	2,378	2,230	2,158	2,158
Retained Earnings	17,650	16,972	14,639	12,647	10,714	8,379
Treasury Stock	-82.07	-84.52	-104.65	-	-	-
Comprensive Income & Other	-46.63	-40.34	-88.55	-47.77	-2.19	22.79
Total Common Equity	21,760	21,048	18,578	16,579	14,620	12,309
Minority Interest	520.98	534.65	598.52	361.94	559.59	557.15
Shareholders' Equity	22,281	21,582	19,176	16,941	15,179	12,867
Total Liabilities & Equity	36,167	33,509	31,192	26,996	24,201	21,464
Total Debt	2,338	1,938	2,586	2,089	1,999	2,076
Net Cash (Debt)	3,313	2,726	1,411	1,944	1,199	326.58
Net Cash Growth	61.47%	93.21%	-27.43%	62.16%	267.04%	-24.45%
Net Cash Per Share	1.89	1.56	0.81	1.11	0.69	0.19
Filing Date Shares Outstanding	1,756	1,752	1,750	1,750	1,750	1,750
Total Common Shares Outstanding	1,756	1,752	1,750	1,750	1,750	1,750
Working Capital	7,213	7,694	7,415	6,221	6,022	5,339
Book Value Per Share	12.39	12.01	10.62	9.47	8.36	7.03
Tangible Book Value	16,682	16,115	13,856	12,207	11,687	9,385
Tangible Book Value Per Share	9.50	9.20	7.92	6.98	6.68	5.36
Buildings	2,312	2,299	1,865	1,503	1,228	1,211
Machinery	4,668	4,438	4,282	3,385	2,817	2,329
Construction In Progress	918.37	913.15	873.16	1,582	2,240	1,830

Source: S&P Capital IQ. Standard template. Financial Sources.